These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 21035550

  • 21. GSH and enzyme responsive nanospheres based on self-assembly of green tea polyphenols and BSA used for target cancer chemotherapy.
    Zhang J, Ren X, Tian X, Zhang P, Chen Z, Hu X, Mei X.
    Colloids Surf B Biointerfaces; 2019 Jan 01; 173():654-661. PubMed ID: 30368213
    [Abstract] [Full Text] [Related]

  • 22. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
    Chen W, Achazi K, Schade B, Haag R.
    J Control Release; 2015 May 10; 205():15-24. PubMed ID: 25445693
    [Abstract] [Full Text] [Related]

  • 23. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S.
    Nanotechnology; 2011 Nov 11; 22(45):455102. PubMed ID: 22019849
    [Abstract] [Full Text] [Related]

  • 24. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.
    Alexander CM, Hamner KL, Maye MM, Dabrowiak JC.
    Bioconjug Chem; 2014 Jul 16; 25(7):1261-71. PubMed ID: 24911830
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery.
    Wang J, Wang M, Zheng M, Guo Q, Wang Y, Wang H, Xie X, Huang F, Gong R.
    Colloids Surf B Biointerfaces; 2015 May 01; 129():63-70. PubMed ID: 25829128
    [Abstract] [Full Text] [Related]

  • 27. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
    Wang H, Yin H, Yan F, Sun M, Du L, Peng W, Li Q, Feng Y, Zhou Y.
    Oncotarget; 2015 Feb 20; 6(5):2827-42. PubMed ID: 25605018
    [Abstract] [Full Text] [Related]

  • 28. Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles.
    Xia Y, Xu T, Zhao M, Hua L, Chen Y, Wang C, Tang Y, Zhu B.
    Int J Mol Sci; 2018 Nov 13; 19(11):. PubMed ID: 30428576
    [Abstract] [Full Text] [Related]

  • 29. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
    Qiu LY, Yan L, Zhang L, Jin YM, Zhao QH.
    Int J Pharm; 2013 Nov 18; 456(2):315-24. PubMed ID: 24016742
    [Abstract] [Full Text] [Related]

  • 30. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M, Abnous K, Sadeghi F, Hosseinkhani H, Ramezani M, Hadizadeh F.
    Int J Pharm; 2016 Mar 16; 500(1-2):162-78. PubMed ID: 26802496
    [Abstract] [Full Text] [Related]

  • 31. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery.
    Zhang H, Li F, Yi J, Gu C, Fan L, Qiao Y, Tao Y, Cheng C, Wu H.
    Eur J Pharm Sci; 2011 Apr 18; 42(5):517-26. PubMed ID: 21352909
    [Abstract] [Full Text] [Related]

  • 32. Preparation of magnetically responsive albumin nanospheres and in vitro drug release studies.
    Ak G, Yɪlmaz H, Sanlɪer SH.
    Artif Cells Nanomed Biotechnol; 2014 Feb 18; 42(1):18-26. PubMed ID: 23419121
    [Abstract] [Full Text] [Related]

  • 33. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
    Cao W, Zhou J, Mann A, Wang Y, Zhu L.
    Biomacromolecules; 2011 Jul 11; 12(7):2697-707. PubMed ID: 21619062
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX.
    Patel K, Sundara Raj B, Chen Y, Lou X.
    Colloids Surf B Biointerfaces; 2016 Apr 01; 140():213-222. PubMed ID: 26764104
    [Abstract] [Full Text] [Related]

  • 35. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L, Li F, Zhang H, Wang Y, Cheng C, Li X, Gu CH, Yang Q, Wu H, Zhang S.
    Biomaterials; 2010 Jul 01; 31(21):5634-42. PubMed ID: 20430433
    [Abstract] [Full Text] [Related]

  • 36. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
    Li X, Yang X, Lin Z, Wang D, Mei D, He B, Wang X, Wang X, Zhang Q, Gao W.
    Eur J Pharm Sci; 2015 Aug 30; 76():95-101. PubMed ID: 25917524
    [Abstract] [Full Text] [Related]

  • 37. Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting.
    Lee KD, Choi SH, Kim DH, Lee HY, Choi KC.
    Arch Pharm Res; 2014 Dec 30; 37(12):1546-53. PubMed ID: 25280540
    [Abstract] [Full Text] [Related]

  • 38. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
    Wen S, Liu H, Cai H, Shen M, Shi X.
    Adv Healthc Mater; 2013 Sep 30; 2(9):1267-76. PubMed ID: 23447549
    [Abstract] [Full Text] [Related]

  • 39. Hyaluronic acid nanogels with enzyme-sensitive cross-linking group for drug delivery.
    Yang C, Wang X, Yao X, Zhang Y, Wu W, Jiang X.
    J Control Release; 2015 May 10; 205():206-17. PubMed ID: 25665867
    [Abstract] [Full Text] [Related]

  • 40. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
    Wu G, Wang Z, Bian X, Du X, Wei C.
    Pharm Biol; 2014 Aug 10; 52(8):978-82. PubMed ID: 25017652
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.